Excellent review of MAPK and oral cancer. On average, how long does it take to confer resistance to MAPK targeted therapies, if only a single subpathway/family is targeted?
Very new interesting function for pore-forming toxins (PFTs). It would be interesting to do a screen of all PFTs, and see how they vary in MAPK responses.
Article